Literature DB >> 12404608

Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.

Z Shamsi1, I Hindmarch.   

Abstract

The use of antihistamines (AHs) has until recently been associated with a number of undesirable side effects, the most troublesome of which is sedation. There are two aspects to sedation. The first, an objectively determined measure based on the results of psychometric tests from controlled trials, and the second, the subject's response to the administration of a drug. Since AHs are largely used in ambulant patients, a complete evaluation of sedation should be performed through standardised objective and subjective tests, shown to be sensitive to the central effects of AHs.An extensive review of the literature identified 76 studies of H(1) receptor antagonists in healthy volunteers, in which assessment of sedation was the primary objective. Results from studies published in peer-reviewed journals which employed a placebo condition as well as a positive internal control using a crossover design were analysed to determine the extent to which a particular antihistamine produced impairments on a battery of psychometric tests. The impairment index for each antihistamine was calculated and subsequently compared with the impairment index obtained for all other AHs.The calculation of this proportional impairment ratio enabled the sedative potential of an individual antihistamine to be identified relative to all other AHs and thus allowed the ranking of AHs with respect to their ability to cause impairments of cognitive and psychomotor function.Findings from this review clearly demonstrate that there are distinct classes of AHs with respect to their ability to impair cognitive function and psychomotor performance. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Year:  2000        PMID: 12404608     DOI: 10.1002/1099-1077(200010)15:1+<::AID-HUP247>3.0.CO;2-S

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  14 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Andrew Boshier; Victoria Cornelius; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.

Authors:  Ian Hindmarch; Leanne Trick; Fran Ridout
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 4.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

5.  Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein.

Authors:  Tanja Obradovic; Glenn G Dobson; Tomotaka Shingaki; Thomas Kungu; Ismael J Hidalgo
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

6.  Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

Authors:  Consuelo García-Gea; Maria Rosa Ballester; Juan Martínez; Rosa Maria Antonijoan; Esther Donado; Iñaki Izquierdo; Manuel-José Barbanoj
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

7.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Effects of sedative and nonsedative antihistamines on prefrontal activity during verbal fluency task in young children: a near-infrared spectroscopy (NIRS) study.

Authors:  Takeo Tsujii; Sayako Masuda; Eriko Yamamoto; Takayuki Ohira; Takekazu Akiyama; Takao Takahashi; Shigeru Watanabe
Journal:  Psychopharmacology (Berl)       Date:  2009-08-25       Impact factor: 4.530

9.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

10.  H1 antihistamines: current status and future directions.

Authors:  F Estelle R Simons; Keith J Simons
Journal:  World Allergy Organ J       Date:  2008-09       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.